Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Jun;18(3-4):267-74.
doi: 10.1016/0166-3542(92)90060-i.

An ELISA system for evaluating antiretroviral activity against Rauscher murine leukemia virus

M G Hollingshead  1 , L Westbrook, M J Ross, J Bailey, K J Qualls, L B Allen
Affiliations

An ELISA system for evaluating antiretroviral activity against Rauscher murine leukemia virus

M G Hollingshead et al. Antiviral Res. 1992 Jun.

Abstract

A system for evaluating the activity of antiviral agents against Rauscher murine leukemia virus (R-MuLV) has been developed using an enzyme linked immunosorbent assay technique. The activity of various antiviral compounds demonstrated in this assay system has been compared to their activity in the UV-XC plaque reduction assay, which has been used historically for evaluating anti-R-MuLV compounds. The assay is based upon detection of R-MuLV encoded p30 protein production in virus infected murine cells. The assay reagents are readily available and the assay system is amenable to automated data collection systems. Cytotoxicity evaluations are conducted in parallel to the Rauscher MuLV ELISA assay in order to assess drug-induced reductions in cell viability. Cytotoxicity evaluations are important to interpretation of the ELISA results since reductions in cell viability reduce viral protein production which would indicate an antiviral drug effect. This system is less sensitive than the classical UV-XC plaque reduction assay; however, it does offer an alternative to the time-consuming and labor-intensive plaque assay.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • A small-molecule dengue virus entry inhibitor.
    Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG. Wang QY, et al. Antimicrob Agents Chemother. 2009 May;53(5):1823-31. doi: 10.1128/AAC.01148-08. Epub 2009 Feb 17. Antimicrob Agents Chemother. 2009. PMID: 19223625 Free PMC article.

References

    1. Chirigos M.A., Rauscher F.J., Kamel I.A., Fanning G.R., Goldin A. Studies with the murine leukemogenic Rauscher virus. I. Chemotherapy studies with in vivo and in vitro assay systems. Cancer Res. 1963;23:762–769. - PubMed
    1. Chirigos M.A., Rauscher F.J., Kamel I.A., Fanning G.R., Goldin A. Studies with the murine leukemogenic Rauscher virus. II. Chemotherapy of virus-induced lymphoid leukemia. Cancer Res. 1963;23:1646–1650. - PubMed
    1. Declève A., Niwa O., Hilgers J., Kaplan H.S. An improved murine leukemia virus immunofluorescence assay. Virology. 1974;57:491–502. - PubMed
    1. Figueiredo L.T.M., Shope R.E. An enzyme immunoassay for dengue antibody using infected cultured mosquito cells as antigen. J. Virol. Methods. 1987;17:191–198. - PubMed
    1. Hartley J.W., Rowe W.P. Clonal cell lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses. Virology. 1975;65:128–134. - PubMed

Publication types

Substances

LinkOut - more resources